1Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease[J]. Annu Rev Neurosci, 1999, 22:123- 144. 被引量：1
2McNaught KSP, Perl DP, Brownell AL, et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinsen's disease[J]. Ann Neurol, 2004, 56:149- 162. 被引量：1
3Meissner W, Hill MP, Tison F, et al. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials[J]. Trends Pharmacol Sci, 2004, 25(5) : 249 - 253. 被引量：1
4Petrucelli L, O' farrell C, Lockhart PJ, et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons [ J ].Neuron, 2002, 36: 1007- 1019. 被引量：1
5Fornai F, Lenzi P, Gesi M, et al. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after protesome inhibition[J]. J Neurosci, 2003, 23 : 8955 - 8966. 被引量：1
8McNaught KS,Perl DP, Brownell AL, ct al. Systemic exposure to proteasome inhibitors causes a progressive model of parkinson 's disease [ J ]. Annals Neurology,2004,56 ( 1 ) : 149 - 162. 被引量：1
9McNaught KS,Perl DP,Brownell AL,et al.Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease[J].AnnNeurol,2004;56(1):149-62. 被引量：1
